Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
NCT00830414
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
medroxyprogesterone acetate
DRUG:
medroxyprogesterone acetate
Sponsor
Teva Pharmaceuticals USA